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Abstract23
Feeding states may affect the performance of colonic prodrugs. The aim is to investigate the 24
influence of feeding regimen in Wistar rats on: i) distribution and pH contents along the gut 25
and ii) metabolism of two colonic prodrugs, diclofenac-β-cyclodextrin and a commercially 26
available control, sulfasalazine, within the caecal and colonic contents. Male Wistar rats were 27
subject to four different feeding regimens, the gut contents characterized (mass and pH) and 28
the metabolism of prodrugs investigated.29
The feeding regimen affects gut contents (mass and pH), more specifically in the stomach 30
and lower intestine, and affects the rate of metabolism of diclofenac-β-cyclodextrin, but not 31
that of sulfasalazine. The latter’s degradation is much faster than that of diclofenac-β-32
cyclodextrin while the metabolism of both prodrugs is faster in colonic (versus caecal) 33
contents. Fasting results in most rapid degradation of diclofenac-β-cyclodextrin, possibly due 34
to lack of competition (absence of food) for microbial enzymatic activity.35
36
37
38
39
40
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1. Introduction41
Colonic drug delivery, for local or systemic action, has many advantages, and can be 42
achieved via different approaches which utilise the properties of the local colonic 43
environment, such as pH and enzymes, for drug release from their carriers (Yang, Chu et al. 44
2002; McConnell, Liu et al. 2009). Cyclodextrins (CDs) have shown promise as colonic 45
carriers. We recently reported the synthesis of diclofenac-β-cyclodextrin conjugate, where the 46
drug is chemically bonded to the CD (Figure 1a) and showed in vitro that the drug is released 47
by enzymes present in the colon (Vieira, Serra et al. 2013). The next step is to establish 48
colonic delivery of diclofenac from this conjugate in an in vivo model.49
In early drug development, drug carriers are often tested in rats, most commonly in fasted 50
rats. The extent of fasted/fed state is however critical to the performance of the drug carrier 51
via its influence on gastro-intestinal transit time, pH, contents and availability of water, and 52
microbial enzymatic activity, to mention but a few factors (Varum, Merchant et al. 2010; 53
Scott, Gratz et al. 2013; Varum, Hatton et al. 2013). This is particularly obvious for orally 54
administered colonic prodrugs, whose onset of absorption depends not only on their physico-55
chemical properties, but also on the time taken for the prodrug to reach the colon, and on the 56
rate of pH/microbial enzyme – controlled drug release. 57
The presence of food in the gastro-intestinal tract reduces gastro-intestinal motility, thereby 58
delaying the arrival of a colonic drug carrier to its site of action (Mittelstadt, Hemenway et al. 59
2005; Varum, Merchant et al. 2010; Varum, Hatton et al. 2013). Food intake also influences 60
the amount of water in the gut that is available for drug dissolution prior to absorption. Food 61
also influences gut contents’ pH, which as well as controlling drug release from pH-62
responsive drug carriers, also influences the ionisation of weakly acidic/basic drugs and thus 63
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their aqueous solubility, stability and absorption (Stella, Borchardt et al. 2007; Varum, 64
Merchant et al. 2010). Food also influences the performance of colonic prodrugs whose 65
conversion to drugs relies on gut bacterial enzymes. Bacterial activity in the colon depends 66
on the quantity and quality of available substrates for fermentation, and determines the 67
intensity and direction of gut bacterial metabolism of prodrugs and thereby drug absorption 68
(Agoram, Woltosz et al. 2001; Mountzouris, Kotzampassi et al. 2009). 69
Given the critical influence of the fasted/fed state on the performance of colonic prodrugs as 70
described above, we determined the influence of different feeding regimens on gastro-71
intestinal contents, pH and metabolism of the colonic prodrug, in order to establish the most 72
appropriate fasted/fed state that should be employed for its in vivo assessment in rats.73
The rat is an appropriate model for use in early drug development; its mean intestinal transit 74
time is comparable to that in humans despite the different gastro-intestinal lengths, transit 75
time is significantly shorter in the fasted state compared to the fed state, as in man, and its 76
gastrointestinal motility is under the control of the migrating myoelectric complex (MMC), 77
again as in man (Tuleu, Andrieux et al. 1999; Mittelstadt, Hemenway et al. 2005). Rats are78
thus widely used as an in vivo model and have been used to assess different colonic prodrugs, 79
including cyclodextrin-based ones (Minami, Hirayama et al. 1998; Makoto Kamada, 80
Fumitoshi Hirayama et al. 2002).81
The different feeding regimens tested were: fed ad libitum, 12-hour fast, 12-hour fast 82
followed by one hour feeding, which was itself followed by either 30 minutes or 4 hours of 83
fast, prior to the animals being killed, and measurements being taken. These four regimens 84
were selected for a number of reasons: firstly, as stated above, most oral drug delivery 85
experiments are conducted on overnight-fasted rats, secondly, a control experiment for the 86
12-hour fast i.e. animals being fed ad libitum, thirdly, a 4-hour fast after feeding, to ensure 87
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complete gastric emptying of food ingested (Booth, Gibson et al. 1986), fourthly, a control88
experiment for the latter, i.e. 30 minutes fast after feeding assures that the ingested food has 89
not arrived in the lower intestine (caecum and colon) (Brown, Greenburgh et al. 1994).90
Concomitantly with diclofenac-β-cyclodextrin conjugate (Figure 1a), the effect of the feeding 91
regimens on the metabolism of sulfasalazine (Figure 1b) - a well-known commercially 92
available colonic prodrug of reference - was also studied. Drug release from diclofenac-β-93
cyclodextrin occurs in the colon by ester hydrolysis and cyclodextrin degradation (Flourié, 94
Molis et al. 1993; Hirayama, Ogata et al. 2000), while sulfasalazine is cleaved in the colon by 95
azoreductase enzymes to 5-aminosalicylic acid (mesalazine) and sulfapyridine (Sousa, 96
Paterson et al. 2008). 97
2. Materials and Methods98
2.1 Materials99
Diclofenac sodium (MW = 318.14 g/mol) and sulfasalazine (MW = 398.394 g/mol) were 100
purchased from Sigma Aldrich. Diclofenac-β-cyclodextrin (MW=1411 g/mol) was 101
synthesized according to the method described by Vieira et al. (Vieira, Serra et al. 2013).102
Sodium chloride, potassium hydroxide, sodium hydroxide, potassium dihydrogen phosphate, 103
HPLC grades acetonitrile, methanol and water were purchased from Fisher Scientifics. 104
Peptone water and yeast extract were obtained from Oxoid Limited (Hampshire, UK). 105
Magnesium sulphate heptahydrate and calcium chloride hexahydrate were obtained from 106
VWR (Leicestershire, UK). Trifluoroacetic acid (TFA) and dimethylformamide (DMF), 107
sodium bicarbonate, haemin, l-cysteine HCl, vitamin K and resazurin were obtained from 108
Sigma Aldrich (Dorset, UK). All other chemicals and solvents were of HPLC reagent grade 109
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and were used without further purification. Phosphate buffer saline (PBS) pH 6.0 and pH 6.8 110
were prepared according to the USPXXIV. 111
2.2 Animals 112
All the procedures had been approved by the School’s Ethical Review Committee and were 113
conducted in accordance with the Home Office standards under the Animals (Scientific Pro-114
cedures) Act, 1986. Studies were performed using healthy adult male Wistar rats (8 weeks, 115
240-250 g) purchased from Harlan Olac Ltd. (Oxfordshire, UK). All animals were housed in 116
rooms with controlled conditions: 20 oC, 40-60% humidity, 15-20 air changes per hour. The 117
animals underwent a period of acclimatization, with free access to standard rat chow and wa-118
ter for 7 days prior the experiment. Twelve hours before the beginning of each experiment, 119
the animals were housed in individual metabolic cages, whose floors were perforated to re-120
strict the animals’ ability to eat their own faeces and allowed the collection of rats’ urine and 121
faeces, separately. Water was available ad libitum through the experiment.122
2.3 Feeding regimens123
Four Groups (A, B, C and D) of 5 rats were given different food intake regimens. Rats from 124
Groups A, B and C were fasted for 12 hours overnight. Subsequently, Group A rats were 125
killed. Groups B and C rats were allowed to feed for one hour, after which they were fasted 126
for either 30 minutes (Group B) or 4 hours (Group C), before being killed. Group D rats were 127
not fasted at all, and were given access to food ad libitum. The different feeding regimens are 128
shown in Figure 2. The animals were killed by a Schedule One Method (CO2 asphyxiation), 129
after which the intestinal tract was removed and the pH and the mass of gut contents were 130
determined as follows.131
Page 7 of 27
Ac
ce
pte
d M
an
us
cri
pt
7
2.4 Determination of the pH and mass of the gastrointestinal luminal contents132
The pH of the contents was measured in situ by placing the pH probe (H160 Portable pH Me-133
ter, Hach, Düsseldorf, Germany) within the luminal contents of each gastrointestinal section.134
The pH was measured at the anterior (labelled I in Figures) and posterior (except for colon),  135
(labeled II in Figures) of each section of the stomach, small intestine (divided into three sec-136
tions approximating to the duodenum, jejunum and ileum), caecum and colon before the gut 137
contents were collected into previously weighed vials. The wet masses were recorded, and 138
the vials were stored at – 80 C. The pH of the distal part of colon contents could not be re-139
liably measured due to its solid nature.140
2.5  Determination of prodrugs’ (diclofenac-β-cyclodextrin and sulfasalazine) stability 141
in caecal and colonic contents142
The stability tests were performed inside an anaerobic workstation (Electrotek 500TG 143
workstation, Electrotek, UK) at 37 C and 70% RH. The caecum and colonic contents from 144
each Group of rats were mixed with PBS – of differing pHs as explained below - in order to 145
obtain a 40% w/w slurry. The pH of the PBS differed for the different samples, but matched 146
the in situ measured pH in the different gastrointestinal sections (section above), in order to 147
maintain the pH of the gut contents. Thus, the gut contents from Groups A and B rats were 148
mixed with PBS pH 6.8, while those from Groups C and D rats were mixed with PBS pH 6.0. 149
The slurries were then homogenized using a glass rod and sieved through an open mesh 150
fabric (Sefar NitexTM, pore size 350 µm) to remove any unhomogenised fibrous material. 151
The sieved faecal slurry was then diluted 50% (w/w) with basal medium containing peptone 152
water, yeast extract, NaCl, K2HPO4, MgSO4·7H2O, CaCl2·6H2O, NaHCO3, haemin, l-153
cysteine HCl, bile salts, Tween 80, vitamin K and resazurin (Basit, Newton et al. 2002; 154
Yadav, Gaisford et al. 2013)155
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Two solutions of each prodrug sulfasalazine (5 mg/mL) and diclofenac-β-cyclodextrin (2.4 156
mg/mL) were prepared in PBS at pH 6.8 and pH 6.0, both containing 4% (v/v) of 157
dimethylformamide (DMF). Subsequently, 100 µL of these solutions were mixed with 900 158
µL of caecal or colonic fluids prepared above; the fluids from Groups A and B rats being 159
mixed with prodrug solutions at pH 6.8, while those from Groups C and D rats were mixed 160
with prodrug solutions at pH 6.0 in order to maintain the pH constant.  The final 161
concentrations of the conjugate, sulfasalazine and DMF were 0.5 mg/mL, 0.24 mg/mL and 162
0.4% (v/v), respectively.163
Thereafter, these mixtures were incubated and shaken at 100 rpm (VXRbasic Vibrax®, 164
Leicestershire, UK), with 50 µL aliquots being withdrawn at times 0, 15, 30, 60, 90, 120, 165
180, 240, 360, 400, 600, 720 and 1440 min. The aliquots were immediately mixed with 100 166
µL of methanol and centrifuged at 10 000 rpm for 10 minutes at room temperature, after 167
which the supernatant was removed and analyzed via HPLC to determine the concentration 168
of the prodrugs and diclofenac.169
2.6  HPLC analysis170
All HPLC runs were performed using an Agilent 1100 series system equipped with a UV de-171
tector and a XTerra reverse phase C-18 column with 5 µm particle size, 4.6 mm internal di-172
ameter and 250 mm length. The mobile phase (consisting of acetonitrile and 0.1% 173
trifluoroacetic acid (TFA) in water) was pumped at a flow rate of 1 mL/min. A gradient 174
system of 0.1% TFA in water (A) and acetonitrile (B) was followed: 0-15 min 25-60% B; 15-175
22 min 60-25% B. The sample injection volume was 20 µl and detection wavelength was 254 176
nm at 30 ºC. Each measurement was performed in triplicate. The results were acquired and 177
processed with the Agilent Chemstation Data System Software 7.178
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2.7 Data analysis179
Statistically significant differences in the total mass of contents between Groups and in the 180
mass and pH of contents per section among Groups were evaluated using One-way analysis 181
of variance (ANOVA), followed by Tukey test. General linear model (repeated measure-182
ments) was utilized to assess the differences of pH contents between Groups with different 183
regimens of food intake (A, B, C and D). The relationship between mass and pH was 184
investigated using Pearson Correlation Coefficient. Degradation kinetics of diclofenac-β-185
cyclodextrin were determined by fitting the percent prodrug remaining versus incubation time 186
curves to a first-order kinetic model, and subsequently calculating reaction rate constant (K) 187
and half-life (t1/2). Statistically significant differences in the rate constant and half-life of 188
diclofenac-β-cyclodextrin conjugate between Groups were analysed using Kruskal–Wallis189
test, with Nemenyi’s post-hoc analysis. All tests, apart from Nemenyi’s test were carried out 190
using SPSS 21.0 for Windows®. Nemenyi’s test was conducted as described in (Jones 2002). 191
Results were considered statistically significant when p < 0.05.192
3. Results and Discussion193
3.1 Influence of feeding regimens on the mass of gastrointestinal contents194
As expected, the feeding regimens influenced the total mass of gastro-intestinal contents 195
(Figure 3), and these were statistically different among the four Groups (ANOVA, p < 0.05). 196
The total gut content weights of the fed Group D rats were almost twice those of the 12-hour 197
fasted Group A rats (post hoc Tukey, p < 0.05). This result in male Wistar rats reflects the 198
previous report in female Wistar rats, where similar values for gut contents are reported199
(McConnell, Basit et al. 2008). When Group B rats were allowed to feed for 1 hour, they ate 200
sufficiently during the hour, such that their total gut contents masses were similar to those in201
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Group D rats which were allowed food ad libitum throughout the experimental duration (p >202
0.05). On the other hand, Group C rats which were fed for 1 hour and fasted for 4 hours prior 203
to being killed had similar mass of gut contents as Group A rats ( p > 0.05).204
Analysis of the distribution of gastrointestinal contents (Figures 4) shows the influence of 205
feeding/fasting states and timings. Groups A and C rats (which were fasted for substantial 206
durations prior to being killed) have similar profiles to each other (Figure 4). Groups B and D 207
rats (which had short/ no fasting times prior to being killed) also had similar profiles to each 208
other (Figure 4). The major difference in the four profiles is the large stomach contents in 209
Groups B and D, compared to minimal stomach contents in Groups A and C. In contrast, the 210
small intestinal contents measured in the duodenum, jejunum and ileum are low and similar 211
across all the groups.212
Fasted animals (Group A) have minimal stomach contents, slowly increasing contents in the 213
duodenum, jejunum and ileum, with most of the gut contents being located in the caecum, 214
and the mass of contents dropping in the colon. A 12-hour fast in Group A rats (Figure 2) 215
means that any food eaten prior to the fast has moved down the gastro-intestinal tract to the 216
caecum. In contrast, the profile for the fed Group D rats is very different compared to that of 217
Group A, with larger masses in the stomach and in the colon of the fed animals.218
Greater variability in the gut (especially stomach) contents is also seen in Group D rats fed ad 219
libitum. Rats with full/partially full stomachs are expected to show variable gastric emptying220
times, leading to variable drug release from the drug carrier, and hence greater variability in 221
the latter’s performance. This explains why most in vivo experiments in laboratory animals 222
are conducted in the fasted state when oral drug absorption is assessed.223
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The similar profiles of Groups B and D rats show that a 30-minutes fast after feeding is obvi-224
ously not sufficient for gastric emptying. In contrast, the similarity of profiles of Group C rats 225
to those of Group A rats shows that gastric emptying has taken place after 4 hours. The226
Group A and C profiles indicate that during the extra 5 experimental hours undergone by 227
Group C rats, the gastrointestinal contents moved down the gut, such that more of it was pre-228
sent in the colon.229
3.2 In situ pH of the gastrointestinal contents 230
The pH of the contents measured along the gastrointestinal tract for the different Groups of231
rats is shown in Figure 5. The profiles are as expected and reflect those previously reported in 232
rats (McConnell, Basit et al. 2008) and man (Dressman, Berardi et al. 1990), the pH value233
being variable in the stomach depending on food intake and its buffering/dilution effect on 234
gastric HCl, rising in the small intestine due to pancreatic juice secretion, and slightly falling 235
in the large intestine due to the production of short chain fatty acids (SCFA) by bacterial fer-236
mentation of dietary fibre. The largest differences among the Groups occur in the early sec-237
tions of the gastrointestinal tract (the stomach) with smaller differences in the caecum and 238
colon (Figure 5). In contrast, the small intestinal pH is immune to the effects of fast-239
ing/feeding regimens. Similarities between pH profiles for Groups A and C rats (repeated 240
measures ANOVA, p > 0.05), and those of Groups B and D rats (repeated measures ANO-241
VA, p > 0.05) shown in Figure 5, reflect the influence of feeding/fasting states and times. 242
Groups A and C rats which have no or limited food in the stomach show a low pH in the first 244
part of the stomach (forestomach) compared to Groups B and D rats which have more food 245
(see Figure 4 for food contents). Indeed, a correlation of 0.7 (Pearson, p < 0.05) was found 246
between the mass of the stomach contents and pH in stomach I in the rats, reflecting the 247
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buffering and dilution effects of food in the stomach (Evans, Pye et al. 1988 ; Fallingborg, 248
Christensen et al. 1989). In contrast to Stomach I the pH in the lower part of the stomach 249
(Stomach II) was low in all Groups of rats, and was independent of food presence (Pearson, p250
> 0.05). This correlates with previous reports that in rats, the non-glandular stomach I251
(forestomach) is used for the storage and mechanical digestion of food (Ghoshal and Bal 252
1989 ), whose presence/absence is the principal factor responsible for the local pH (Ward and 253
Coates 1987), while the pH in the glandular HCl-secreting Stomach II is influenced mainly254
by microbial products, despite HCl-secretion being stimulated by the presence of food (Ward 255
and Coates 1987). It must be noted that in man, the whole stomach is glandular and harbours 256
few bacteria, in contrast to the large bacterial numbers in rats (Kararli 1995). 257
As mentioned above, the pH profiles of the four Groups of rats diverge at the large intestinal 258
caecal and colonic fractions. Although differences are small, the lowest pHs are seen in 259
Groups C and D, with the highest in Groups A and B. Comparison of Figures 4 and 5 suggest 260
a correlation between mass of contents and pH measured. Indeed a strong correlation (r = -261
0.9, Person p < 0.05) was found between the content’s mass and the pH in the first part of the 262
colon (Colon I) when all the rats’ data was analysed, i.e. n = 20. This reflects the production 263
of bacterial fermentation products, the short chain fatty acids (acetate, propionate and bu-264
tyrate) (Scott, Gratz et al. 2013); with a greater mass of dietary fibre leading to greater bacte-265
rial metabolism and production of short fatty acids (Ferguson, Tasman-Jones et al. 2000; 266
Paturi, Butts et al. 2012). 267
A higher pH in the large intestine of Group A fasted rats (compared to Group D fed rats) re-268
flects previous reports in rats (McConnell, Basit et al. 2008) and in man (Evans, Pye et al. 269
1988 ; Fallingborg, Christensen et al. 1989) and may be explained by their lower concentra-270
tions of SCFA compared to rats fed ad libitum (Mountzouris, Kotzampassi et al. 2009). 271
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Similar large intestinal pH in Groups A and B suggests that food ingested by Group B rats 272
during the 1 hour feeding has not travelled down the gastro-intestinal tract during the 30 273
minutes fast prior to measurement. Meanwhile, the lower large intestinal pH in Group C rats 274
suggests that food ingested prior to a 4-hour fast has travelled down the gastro-intestinal tract 275
to some extent. This shows the importance of the fasting/fed states and feeding regimens 276
when evaluating colonic drug carriers in the rat in vivo model. The fasted rat (most 277
commonly used model) may demonstrate a poor performance of a pH-controlled colonic drug 278
carrier, due to an insufficiently low pH in the colon, rather than due to a poor formulation. On 279
the other hand, while the fed rat may possess the correct (low) colonic pH required for drug 280
release from such a pH-controlled carrier, variable feeding by a Group of animals could lead 281
to variability in gut contents, transit times, drug release and absorption profiles, which could 282
in turn mask the true potential of the colonic drug carrier. 283
3.3 Stability of diclofenac-β-cyclodextrin and sulfasalazine prodrugs in caecum and 284
colon contents.285
The stability of the prodrugs in caecal and colonic fluids is shown in Figures 6. Moreover 286
Figure 6 indicates that the disappearance of diclofenac-β-cyclodextrin coincides with the ap-287
pearance of free diclofenac in each release medium; therefore confirming the prodrug is able 288
to liberate the drug in a colonic environment. It can be seen that, in all the animal Groups:289
1. Degradation of sulfasalazine is much faster than that of diclofenac-β-cyclodextrin in 290
both milieus. Sulfasalazine is degraded by azoreductases, which are produced by many dif-291
ferent bacterial species in the large intestine. The supply of the enzyme azoreductase being292
almost unlimited, sulfasalazine’s degradation can take place without delay, and does not seem 293
to be influenced by the feeding regimen. In fact, the sulfasalazine degradation was so fast that 294
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the degradation profiles have few time points, and the curves were not fitted for further anal-295
ysis for reaction rates and half-lives.296
In contrast, the cyclodextrin conjugate’s metabolism is much more complex, and involves 297
two types of enzymes, amylase and esterase. The esterase can only act after the amylase has298
started degrading the cyclodextrin carrier as reported previously (Hirayama, Ogata et al. 299
2000). Moreover, the compounds formed in the initial stages of amylase-degradation of300
cyclodextrin - high-membered maltooligomers (maltohexaose, maltopentaose, maltotetraose)301
- are themselves substrates for the amylases and can therefore act as competitive inhibitors of 302
the enzymatic reaction (Suetsugu, Koyama et al. 1974; Jodal, Kandra et al. 1984). In addition, 303
while the lower-membered maltooligomers (glucose, maltose and maltotriose) formed during 304
the reaction are not substrates for the amylase, they can become “non-competitive” enzyme 305
inhibitors by linking to the enzyme protein (Jodal, Kandra et al. 1984). Thus, the diclofenac-306
CD conjugate shows potential as a sustained-release formulation.307
2. The degradation of both prodrugs is faster in colonic contents, compared to caecal contents308
(Table 1). This could be due to a number of reasons; such as the caecal slurry having a lower 309
bacterial concentration (due to its greater liquid content), or the caecal slurry being more nu-310
trient-rich (the caecum being the main site of bacterial fermentation), such that less prodrug is 311
metabolized by the bacteria as a source of substrate.312
3. The rate of CD-drug conjugate’s degradation by bacterial enzymes was influenced by the 313
feeding regimen in the colon (Figure 6). Degradation was fastest from Groups A and B fasted 314
rats, followed by Group D, followed by Group C (Table 1). This order of degradation rates K 315
was statistically significant (p < 0.05, Kruskal Wallis, followed by Nemenyi’s test). The fast 316
prodrug degradation in Group A rats (which had been fasted for 12 hours) could be due to a 317
lack of nutrient in the colon for the bacterial enzymes to act on, which therefore act exclu-318
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sively on the prodrug, degrading the latter. Similarly, in Group B rats, the colon is nutrient-319
poor and exclusive enzyme action on the prodrug leads to the latter’s fast degradation. Al-320
though Group B rats were fed for one hour (Figure 2), the food had not had time to move 321
down to the colon by the time the rats were killed 30 minutes after the one-hour feeding time.322
In contrast, food and nutrient were present in the colon of Group D fed rats, and competition 323
between nutrient and prodrug for enzyme action led to slower prodrug degradation. The 324
slower rate of prodrug degradation in Group C rats (compared to Group D rats) shows an 325
even greater amount of nutrient in the colon of Group C rats, and hence greater competition 326
of enzyme action. It is possible that the bolus intake of food by Group C rats during the one 327
hour feeding arrives in the colon at some point during the four hours of fasting, such that 328
there is overwhelming competition for the enzyme.329
Overall, it is interesting to note that the rates of degradation of diclofenac-β-cyclodextrin in 330
rats’s colonic contents in Group A and B is close to the rate of degradation observed in the 331
human faecal slurries collected from individuals without any food intake control, as reported 332
previously (Vieira, Serra et al. 2013).333
In contrast to the obvious influence of feeding regimen on prodrug degradation in the colon, 334
the influence was less obvious in the caecum. The degradation curves for all rat Groups have 335
similar profiles, especially at the beginning of the in vitro degradation reaction (Figure 6). 336
The caecum has su h a high content of material in all rat Groups (Figure 4) that feed-337
ing/fasting did not seem to alter the nutrient content and subsequently, any competition be-338
tween nutrient and prodrug for enzyme action. One point to note though is the completion of 339
prodrug degradation in Group A fasted rats’ caecal contents at 600 minutes (Figure 6) in con-340
trast to the other Groups. This correlates with the fact that Group A fasted rats had a lowest 341
amount of nutrient (and hence competition for enzyme action) in their caecum.342
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4. Conclusions343
This study demonstrates the importance of feeding regimens, specifically the timing of meal344
ingestion, on the gastrointestinal conditions in rats and how this influences the metabolism of 345
colonic prodrugs. In addition to changes in the distribution of gut contents along the GI tract, 346
which directly affects the gastrointestinal transit time, different feeding regimens are accom-347
panied by changes in the pH of gut contents, specifically in the stomach and large intestine. 348
Moreover, differential gut contents in the large intestine have an impact on the microbiota 349
activity, which affects the rate of diclofenac-β-cyclodextrin metabolism and hence drug re-350
lease and absorption. We also show that the different feeding regimens did not seem to im-351
pact on the metabolism of sulfasalazine, which was rapidly metabolized. Thus, we conclude 352
that while feeding regimen influences the performance of the colonic prodrug, diclofenac-β-353
cyclodextrin, that influence has to be measured for each prodrug individually, given the dif-354
ferent metabolic pathways of different colonic carriers.355
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Table 1: Degradation rate (k, min−1) and half-life (t1/2 , min) for diclofenac-β-cyclodextrin in 437
cecal and colonic contents of rat Groups A, B, C and D.438
439
CECUM COLON
Groups k (min-1) t1/2 (min) k (min
-1) t1/2 (min)
A 0.004 ± 0.001 185 ± 22 0.016 ± 0.001 44 ± 2
B 0.002 ± 0.000 397 ± 56 0.013 ± 0.005 60 ± 22
C 0.001 ± 0.000 490 ± 76 0.003 ± 0.001 250 ± 43
D 0.003 ± 0.000 249 ± 27 0.008 ± 0.002 90 ± 16
440
441
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Highlights442
- Rats subject to different feeding regimens (4 groups) 443
- Gastrointestinal contents characterized in terms of mass and pH 444
- Stability of diclofenac-β-cyclodextrin versus sulfasalazine: influence of feeding regimen445
- Feeding state affects diclofenac-β-cyclodextrin but not sulfasalazine metabolism.446
- Diclofenac-β-cyclodextrin degradation is fastest in fasted state447
448
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Figure 1 Structures of diclofenac-β-cyclodextrin (a) and of the control, sulfasalazine (b)  
Figure 2 Schematic representation of the different feeding regimens of the rat Groups A, B, 
C and D. A: 12-hour fast; B: 12-hour fast followed by 1-hour feeding, followed by 30-min 
fast; C: 12-hour fast, followed by1-hour feeding, followed by 4-hour fast; D: fed ad libitum. 
Figure 3 Total mass of gastrointestinal contents in healthy male rats in the different Groups. 
A: 12 hours fast, B: 12 hours fast then 1 hour fed then 30 min fast, C: 12 hours fast then 1 
hour fed then 4 hours fast; D; fed. Each bar represents mean ± S.D, n = 5. 
Figure 4 Mass of luminal contents in the different gastrointestinal sections in the rat Groups. 
Each bar represents mean ± S.D. n = 5 
Figure 5 In situ pH of gastrointestinal contents in the different sections of the gastrointestinal 
tract in the rat Groups. I and II refer to the anterior and posterior parts respectively. Each 
point represents mean ± S.D, n = 5. 
Figure 6 Mean levels of diclofenac-β-cyclodextrin (A, C) and sulfasalazine (B, D) remaining 
when prodrugs were incubated in caecal and colonic contents from rats from Group A (●), B 
(▲), C (■), and D (). Means of diclofenac (A, C) appearance when diclofenac-β-
cyclodextrin was incubated in caecal and colonic contents from Group A (○), B (∆), C (□), 
and D (◊). Each point represents mean ± S.D, n = 3. 
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